Sharp Clinical Launches Direct-to-Patient Service with New Partnerships
Sharp Clinical Services, part of UDG Healthcare and a provider of global clinical supply services, has signed a central pharmacy partnership deal and developed a holistic patient support program with its sister company, Ashfield.
The company has signed a partnership agreement with European central pharmacy Hubertus, Germany, which will support Sharp’s direct-to-patient logistics service for its clinical trial clients in Europe and neighboring nations.
The partnership will further enable Sharp to respond to the increasing demand for distribution direct-to-patients’ homes as part of virtual and hybrid trials which are expected to become the norm in the near future.
It’s the second such agreement for Sharp, which has a similar partnership in place in the US. The agreement with Hubertus means Sharp now has the foundation to offer direct-to-patient services in the two largest markets in the world.
Sascha Sonnenberg, Global Head of Business Development, Sharp Clinical Services, said: “I’m excited to see how we have successfully worked together with our partners and colleagues to establish a comprehensive solution to the benefit of our clients and patients participating in clinical trials.
“This is not just a temporary option during the COVID-19 situation but will experience an increasing demand in a post-pandemic era.”
Sharp has also joined forces with the Patient Solutions business unit of its sister company, Ashfield. The service will provide clinical educator-led ministering in key areas such as injection training, infusions and blood pressure monitoring to patients in their own home.
This service can be delivered either through in-person visits in Europe or remotely in both the US and Europe as part of a holistic and compliant solution for clinical trial sponsors.
Sascha added, “The breadth and depth of this solution is a unique offering to sponsors in the clinical services market. We can now provide a holistic solution-delivering drugs directly to trial participants as well as supporting them throughout their participation.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
